Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析

◆英語タイトル:Euro-Diagnostica AB - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012948
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers products such as alpha-MSH euria, chromogranin A euria, complement system alternative pathway WIESLAB, complement system classical pathway, complement system MBL pathway and therapy areas are rheumatoid arthritis, goodpasture’s syndrome, complement deficiency, connective tissue disorders, congenital heart block, inflammatory bowel disease and autoimmune gastroenterology, among others. The company offers custom manufacturing and lab services. It has its operations in the UK, China, Singapore, Switzerland, Germany and the Netherlands. Euro Diagnostica is headquartered in Malmo, Sweden.

Euro-Diagnostica AB – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Euro-Diagnostica AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Euro-Diagnostica AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Euro-Diagnostica AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Euro-Diagnostica AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Euro-Diagnostica AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Euro-Diagnostica AB, Medical Equipment, Deal Details 10
Partnerships 10
Gyros Protein Technologies Enters into Distribution Agreement with Euro Diagnostica 10
Euro-Diagnostica Enters Into Distribution Agreement With Eurospital 11
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 12
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 13
Merger 14
Biomonitor Merges with Euro-Diagnostica 14
Acquisition 15
Euro-Diagnostica Acquires Vita Diagnostika 15
Euro-Diagnostica AB – Key Competitors 16
Euro-Diagnostica AB – Key Employees 17
Euro-Diagnostica AB – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
Mar 20, 2017: New iLite FGF21 Responsive Reporter Gene Cell Line With Improved Sensitivity 19
Dec 06, 2016: Euro Diagnostica announces launch of a new Product Line – iLite Assay Ready Cells for determination of ADCC activity 20
Apr 22, 2016: Euro Diagnostica to present new data at the PEGS Summit in Boston 21
Apr 12, 2016: Euro Diagnostica announces launch of two new products – iLite Assay Ready Cells for Insulin and FGF21 22
Mar 30, 2016: New research on the use of an cell-based reporter gene iLite assay to be presented at the 10th International Congress on Autoimmunity 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Euro-Diagnostica AB, Medical Equipment, Key Facts 2
Euro-Diagnostica AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Euro-Diagnostica AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Euro-Diagnostica AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Euro-Diagnostica AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Euro-Diagnostica AB, Deals By Market, 2011 to YTD 2017 8
Euro-Diagnostica AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Gyros Protein Technologies Enters into Distribution Agreement with Euro Diagnostica 10
Euro-Diagnostica Enters Into Distribution Agreement With Eurospital 11
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 12
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 13
Biomonitor Merges with Euro-Diagnostica 14
Euro-Diagnostica Acquires Vita Diagnostika 15
Euro-Diagnostica AB, Key Competitors 16
Euro-Diagnostica AB, Key Employees 17
Euro-Diagnostica AB, Other Locations 18
Euro-Diagnostica AB, Subsidiaries 18

★海外企業調査レポート[Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medanito SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Medanito SA (Medanito) is an upstream energy company. The company operates in the business of exploration and production of oil and natural gas with participation in the development of unconventional reserves. It operates in the gathering and processing of natural gas liquids (NGL); and gas- …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務情報
    AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Dometic Group AB:企業の戦略・SWOT・財務情報
    Dometic Group AB - Strategy, SWOT and Corporate Finance Report Summary Dometic Group AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Juniper Networks Inc (JNPR):企業の財務・戦略的SWOT分析
    Juniper Networks Inc (JNPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Sohar Power Company SAOG:発電所・企業SWOT分析
    Sohar Power Company SAOG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Arden Partners Plc (ARDN):企業の財務・戦略的SWOT分析
    Summary Arden Partners Plc (Arden) is a multi-service stockbroker that provides a range of financial services to corporate and institutional clients. The company offers research, distribution, execution and corporate finance services. Its distribution services include providing unique trading though …
  • Basin Electric Power Cooperative:企業の戦略・SWOT・財務分析
    Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report Summary Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • St. Jude Medical, Inc.:企業のM&A・事業提携・投資動向
    St. Jude Medical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's St. Jude Medical, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Aditya Birla Retail Limited:企業の戦略的SWOT分析
    Aditya Birla Retail Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Bosch Rexroth AG:企業の戦略的SWOT分析
    Bosch Rexroth AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Laboratoires Pierre Fabre SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …
  • Celulose Irani S.A.:企業の戦略・SWOT・財務情報
    Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report Summary Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Horizon Pharma Plc (HZNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed pro …
  • Targa Resources Partners LP (NGLS PR A)-石油・ガス分野:企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • Triple-S Management Corp (GTS):企業の財務・戦略的SWOT分析
    Triple-S Management Corp (GTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Alvogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company’s product portfolio comprises generic medications in various therapeutic areas that include oncology, cardiology, respiratory, neurology and gastroenterology. A …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆